Literature DB >> 26774196

MicroRNAs in cholangiopathies: Potential diagnostic and therapeutic tools.

Aitor Esparza-Baquer1, Ibone Labiano1, Luis Bujanda2, María J Perugorria3, Jesús M Banales4.   

Abstract

Cholangiopathies are the group of diseases targeting the bile duct epithelial cells (i.e. cholangiocytes). These disorders arise from different etiologies and represent a current diagnostic, prognostic and therapeutic challenge. Different molecular mechanisms participate in the development and progression of each type of biliary disease. However, microRNA deregulation is a common central event occurring in all of them that plays a key role in their pathogenesis. MicroRNAs are highly stable small non-coding RNAs present in cells, extracellular microvesicles and biofluids, representing valuable diagnostic tools and potential targets for therapy. In the following sections, the most novel and significant discoveries in this field are summarized and their potential clinical value is highlighted.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Mesh:

Substances:

Year:  2016        PMID: 26774196     DOI: 10.1016/j.clinre.2015.10.001

Source DB:  PubMed          Journal:  Clin Res Hepatol Gastroenterol        ISSN: 2210-7401            Impact factor:   2.947


  8 in total

1.  MicroRNAs and cholangiocarcinoma: elucidating the effects of tiny giants.

Authors:  Vik Meadows; Heather Francis
Journal:  AME Med J       Date:  2018-10-04

Review 2.  Cholangiocarcinoma 2020: the next horizon in mechanisms and management.

Authors:  Jesus M Banales; Jose J G Marin; Angela Lamarca; Pedro M Rodrigues; Shahid A Khan; Lewis R Roberts; Vincenzo Cardinale; Guido Carpino; Jesper B Andersen; Chiara Braconi; Diego F Calvisi; Maria J Perugorria; Luca Fabris; Luke Boulter; Rocio I R Macias; Eugenio Gaudio; Domenico Alvaro; Sergio A Gradilone; Mario Strazzabosco; Marco Marzioni; Cédric Coulouarn; Laura Fouassier; Chiara Raggi; Pietro Invernizzi; Joachim C Mertens; Anja Moncsek; Sumera Rizvi; Julie Heimbach; Bas Groot Koerkamp; Jordi Bruix; Alejandro Forner; John Bridgewater; Juan W Valle; Gregory J Gores
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-06-30       Impact factor: 46.802

Review 3.  Cholangiocarcinoma: Classification, Histopathology and Molecular Carcinogenesis.

Authors:  Gábor Lendvai; Tímea Szekerczés; Idikó Illyés; Réka Dóra; Endre Kontsek; Alíz Gógl; András Kiss; Klára Werling; Ilona Kovalszky; Zsuzsa Schaff; Katalin Borka
Journal:  Pathol Oncol Res       Date:  2018-11-17       Impact factor: 3.201

Review 4.  Biomarkers for primary biliary cholangitis: current perspectives.

Authors:  Elias Kouroumalis; Demetrius Samonakis; Argyro Voumvouraki
Journal:  Hepat Med       Date:  2018-06-18

Review 5.  Epigenetic Modifications in Generalized Autoimmune Epithelitis: Sjögren's Syndrome and Primary Biliary Cholangitis.

Authors:  Pinelopi Arvaniti; Kalliopi Zachou; Aggeliki Lyberopoulou; Nikolaos K Gatselis; Wesley H Brooks; George N Dalekos; Yves Renaudineau
Journal:  Epigenomes       Date:  2019-08-08

6.  Discovery of glycocholic acid and taurochenodeoxycholic acid as phenotypic biomarkers in cholangiocarcinoma.

Authors:  Won-Suk Song; Hae-Min Park; Jung Min Ha; Sung Gyu Shin; Han-Gyu Park; Joonwon Kim; Tianzi Zhang; Da-Hee Ahn; Sung-Min Kim; Yung-Hun Yang; Jae Hyun Jeong; Ashleigh B Theberge; Byung-Gee Kim; Jong Kyun Lee; Yun-Gon Kim
Journal:  Sci Rep       Date:  2018-07-23       Impact factor: 4.379

7.  Patients with Cholangiocarcinoma Present Specific RNA Profiles in Serum and Urine Extracellular Vesicles Mirroring the Tumor Expression: Novel Liquid Biopsy Biomarkers for Disease Diagnosis.

Authors:  Ainhoa Lapitz; Ander Arbelaiz; Colm J O'Rourke; Jose L Lavin; Adelaida La Casta; Cesar Ibarra; Juan P Jimeno; Alvaro Santos-Laso; Laura Izquierdo-Sanchez; Marcin Krawczyk; Maria J Perugorria; Raul Jimenez-Aguero; Alberto Sanchez-Campos; Ioana Riaño; Esperanza Gónzalez; Frank Lammert; Marco Marzioni; Rocio I R Macias; Jose J G Marin; Tom H Karlsen; Luis Bujanda; Juan M Falcón-Pérez; Jesper B Andersen; Ana M Aransay; Pedro M Rodrigues; Jesus M Banales
Journal:  Cells       Date:  2020-03-14       Impact factor: 6.600

Review 8.  Pathological, molecular, and clinical characteristics of cholangiocarcinoma: A comprehensive review.

Authors:  Mukul Vij; Yogesh Puri; Ashwin Rammohan; Gowripriya G; Rajesh Rajalingam; Ilankumaran Kaliamoorthy; Mohamed Rela
Journal:  World J Gastrointest Oncol       Date:  2022-03-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.